Lonza Group Ag Debt Issuance/Retirement Net - Total 2012-2024 | LZAGY

Lonza Group Ag annual/quarterly debt issuance/retirement net - total history and growth rate from 2012 to 2024. Debt issuance/retirement net - total can be defined as the total amount of short term and long term borrowings repaid and issued.
  • Lonza Group Ag debt issuance/retirement net - total for the quarter ending December 31, 2024 was $2.181B, a 15142.96% decline year-over-year.
  • Lonza Group Ag debt issuance/retirement net - total for the twelve months ending December 31, 2024 was $3.775B, a 1272.91% decline year-over-year.
  • Lonza Group Ag annual debt issuance/retirement net - total for 2023 was $0.908B, a 508.65% decline from 2022.
  • Lonza Group Ag annual debt issuance/retirement net - total for 2022 was $-0.222B, a 54.58% decline from 2021.
  • Lonza Group Ag annual debt issuance/retirement net - total for 2021 was $-0.489B, a 469.78% decline from 2020.
Lonza Group Ag Annual Debt Issuance/Retirement Net - Total
(Millions of US $)
2023 $908
2022 $-222
2021 $-489
2020 $132
2019 $-482
2017 $121
2016 $-135
2015 $-129
2014 $2
2013 $-1
2012 $324
2011 $426
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $49.468B $7.468B
Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The company's Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $232.634B 27.97
Boston Scientific (BSX) United States $152.531B 38.19
Stryker (SYK) United States $145.427B 30.41
EssilorLuxottica (ESLOY) France $127.535B 0.00
Medtronic (MDT) Ireland $109.709B 15.55
Haleon (HLN) United Kingdom $49.754B 28.33
ResMed (RMD) United States $36.224B 27.21
GE HealthCare Technologies (GEHC) United States $32.583B 15.47
Agilent Technologies (A) United States $32.148B 20.88
Terumo (TRUMY) Japan $26.857B 34.88
Insulet (PODD) United States $22.748B 89.29
Koninklijke Philips (PHG) Netherlands $21.431B 15.40
Zimmer Biomet Holdings (ZBH) United States $18.172B 11.67
Baxter (BAX) United States $15.441B 11.53
Smith & Nephew SNATS (SNN) United Kingdom $12.754B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.637B 0.00
Bio-Rad Laboratories (BIO) United States $6.002B 20.89
Lantheus Holdings (LNTH) United States $5.375B 13.56
Prestige Consumer Healthcare (PBH) United States $4.194B 18.74
Perrigo (PRGO) Ireland $3.646B 9.24
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.346B 15.24
ICU Medical (ICUI) United States $3.213B 23.69
Envista Holdings (NVST) United States $3.174B 26.38
GN Store Nord (GNNDY) Denmark $2.155B 17.85
QuidelOrtho (QDEL) United States $2.048B 14.09
LeMaitre Vascular (LMAT) United States $1.872B 41.85
AtriCure (ATRC) United States $1.719B 0.00
Neogen (NEOG) United States $1.302B 16.67
Acuren (TIC) United States $1.300B 0.00
AdaptHealth (AHCO) United States $1.196B 12.14
Green Thumb Industries (GTBIF) United States $1.110B 24.97
BioLife Solutions (BLFS) United States $1.016B 0.00
Kestra Medical Technologies (KMTS) United States $1.008B 0.00
Phibro Animal Health (PAHC) United States $0.986B 12.60
InMode (INMD) Israel $0.930B 9.37
Evolus (EOLS) United States $0.642B 0.00
CeriBell (CBLL) United States $0.612B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.565B 0.00
Curaleaf Holdings (CURLF) Canada $0.544B 0.00
Valneva SE (VALN) France $0.519B 0.00
Owens & Minor (OMI) United States $0.517B 4.29
Capricor Therapeutics (CAPR) United States $0.509B 0.00
Surmodics (SRDX) United States $0.422B 0.00
Tilray Brands (TLRY) Canada $0.403B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.366B 0.00
SNDL (SNDL) Canada $0.336B 0.00
VAREX IMAGING (VREX) United States $0.326B 11.98
Aurora Cannabis (ACB) Canada $0.302B 53.70
Cresco Labs (CRLBF) United States $0.277B 0.00
Cerus (CERS) United States $0.275B 0.00
Viemed Healthcare (VMD) United States $0.268B 22.63
Sanara MedTech (SMTI) United States $0.259B 0.00
ZimVie (ZIMV) United States $0.258B 11.75
Sanuwave Health (SNWV) United States $0.242B 0.00
Canopy Growth (CGC) Canada $0.222B 0.00
OraSure Technologies (OSUR) United States $0.221B 0.00
Verano Holdings (VRNOF) United States $0.216B 0.00
Quanterix (QTRX) United States $0.211B 0.00
TriSalus Life Sciences (TLSI) United States $0.196B 0.00
Biote (BTMD) United States $0.194B 5.46
Brainsway (BWAY) Israel $0.192B 50.95
High Tide (HITI) Canada $0.185B 0.00
Omeros (OMER) United States $0.184B 0.00
Utah Medical Products (UTMD) United States $0.182B 14.81
Organigram Global (OGI) Canada $0.178B 0.00
Exagen (XGN) United States $0.157B 0.00
Vireo Growth (VREOF) United States $0.139B 0.00
FitLife Brands (FTLF) United States $0.135B 16.58
Jin Medical (ZJYL) China $0.122B 0.00
TerrAscend (TSNDF) Canada $0.098B 0.00
MacroGenics (MGNX) United States $0.095B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.092B 0.00
Veru (VERU) United States $0.090B 0.00
Fonar (FONR) United States $0.090B 11.62
Agape ATP (ATPC) $0.081B 0.00
Quipt Home Medical (QIPT) United States $0.078B 0.00
InterCure (INCR) Israel $0.070B 0.00
Zynex (ZYXI) United States $0.065B 0.00
Cytosorbents (CTSO) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.062B 0.00
Apyx Medical (APYX) United States $0.061B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
Modular Medical (MODD) United States $0.048B 0.00
United-Guardian (UG) United States $0.037B 12.94
Nephros (NEPH) United States $0.035B 46.71
Rockwell Medical (RMTI) United States $0.035B 0.00
Allurion Technologies (ALUR) United States $0.021B 0.00
Safety Shot (SHOT) United States $0.019B 0.00
INLIF (INLF) $0.017B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.010B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00